Genpact Net Worth
Genpact Net Worth Breakdown | G |
Genpact Net Worth Analysis
Genpact's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Genpact's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Genpact's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Genpact's net worth analysis. One common approach is to calculate Genpact's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Genpact's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Genpact's net worth. This approach calculates the present value of Genpact's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Genpact's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Genpact's net worth. This involves comparing Genpact's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Genpact's net worth relative to its peers.
Enterprise Value |
|
To determine if Genpact is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Genpact's net worth research are outlined below:
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Securian Asset Management Inc. Has 527,000 Holdings in Genpact Limited |
Genpact Quarterly Good Will |
|
Genpact uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Genpact Limited. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Genpact's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Genpact Target Price Consensus
Genpact target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Genpact's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Buy |
Most Genpact analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Genpact stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Genpact Limited, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGenpact Target Price Projection
Genpact's current and average target prices are 51.11 and 47.40, respectively. The current price of Genpact is the price at which Genpact Limited is currently trading. On the other hand, Genpact's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Genpact Target Price
Know Genpact's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genpact is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genpact Limited backward and forwards among themselves. Genpact's institutional investor refers to the entity that pools money to purchase Genpact's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Fidelity International Ltd | 2024-12-31 | 3.7 M | Jpmorgan Chase & Co | 2024-12-31 | 3.4 M | Alliancebernstein L.p. | 2024-12-31 | 2.9 M | Citadel Advisors Llc | 2024-12-31 | 2.3 M | Tandem Investment Advisors Inc | 2024-12-31 | 2.1 M | Norges Bank | 2024-12-31 | 2.1 M | Fuller & Thaler Asset Management Inc | 2024-12-31 | 1.9 M | Orbis Allan Gray Ltd | 2024-12-31 | 1.8 M | Artisan Partners Limited Partnership | 2024-12-31 | 1.7 M | Fmr Inc | 2024-12-31 | 20.1 M | Vanguard Group Inc | 2024-12-31 | 17 M |
Follow Genpact's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current capitalization of 8.87 B.Market Cap |
|
Project Genpact's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.17 | 0.10 | |
| Return On Assets | 0.10 | 0.06 | |
| Return On Equity | 0.21 | 0.13 |
When accessing Genpact's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Genpact's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Genpact's profitability and make more informed investment decisions.
Evaluate Genpact's management efficiency
Genpact Limited has return on total asset of 0.089 % which means that for every 100 dollars spent on assets, it generated a profit of $0.089. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2215 %, implying that it made 0.2215 on every $100 invested by shareholders. Genpact's management efficiency ratios could be used to measure how well Genpact manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.10. The current Return On Capital Employed is estimated to decrease to 0.10. At this time, Genpact's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Genpact's current Intangibles To Total Assets is estimated to increase to 0.45, while Total Assets are projected to decrease to roughly 3.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.40 | 12.73 | |
| Tangible Book Value Per Share | 3.88 | 4.08 | |
| Enterprise Value Over EBITDA | 8.50 | 9.56 | |
| Price Book Value Ratio | 3.21 | 2.64 | |
| Enterprise Value Multiple | 8.50 | 9.56 | |
| Price Fair Value | 3.21 | 2.64 | |
| Enterprise Value | 7.2 B | 4 B |
At Genpact Limited, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 2.0224 | Revenue | Quarterly Revenue Growth 0.089 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genpact insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genpact's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Genpact insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Genpact Corporate Filings
F4 | 14th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 3rd of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 20th of February 2025 Other Reports | ViewVerify | |
| 12th of February 2025 Other Reports | ViewVerify |
Genpact Earnings Estimation Breakdown
The calculation of Genpact's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Genpact is estimated to be 0.793 with the future projection ranging from a low of 0.78 to a high of 0.8036. Please be aware that this consensus of annual earnings estimates for Genpact Limited is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.78 Lowest | Expected EPS | 0.80 Highest |
Genpact Earnings Projection Consensus
Suppose the current estimates of Genpact's value are higher than the current market price of the Genpact stock. In this case, investors may conclude that Genpact is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Genpact's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 10 | 94.57% | 0.91 | 0.793 | 2.85 |
Genpact Earnings History
Earnings estimate consensus by Genpact Limited analysts from Wall Street is used by the market to judge Genpact's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Genpact's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Genpact Quarterly Gross Profit |
|
Genpact Earnings per Share Projection vs Actual
Actual Earning per Share of Genpact refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Genpact Limited predict the company's earnings will be in the future. The higher the earnings per share of Genpact, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Genpact Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Genpact, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Genpact should always be considered in relation to other companies to make a more educated investment decision.Genpact Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Genpact's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-03 | 2024-12-31 | 0.862 | 0.91 | 0.048 | 5 | ||
2024-11-04 | 2024-09-30 | 0.8 | 0.85 | 0.05 | 6 | ||
2024-08-08 | 2024-06-30 | 0.72 | 0.72 | 0.0 | 0 | ||
2024-05-09 | 2024-03-31 | 0.68 | 0.73 | 0.05 | 7 | ||
2024-02-08 | 2023-12-31 | 0.74 | 0.82 | 0.08 | 10 | ||
2023-11-08 | 2023-09-30 | 0.73 | 0.76 | 0.03 | 4 | ||
2023-08-09 | 2023-06-30 | 0.69 | 0.72 | 0.03 | 4 | ||
2023-05-10 | 2023-03-31 | 0.65 | 0.68 | 0.03 | 4 | ||
2023-02-09 | 2022-12-31 | 0.68 | 0.7 | 0.02 | 2 | ||
2022-11-09 | 2022-09-30 | 0.69 | 0.75 | 0.06 | 8 | ||
2022-08-04 | 2022-06-30 | 0.64 | 0.7 | 0.06 | 9 | ||
2022-05-05 | 2022-03-31 | 0.53 | 0.6 | 0.07 | 13 | ||
2022-02-11 | 2021-12-31 | 0.52 | 0.54 | 0.02 | 3 | ||
2021-11-09 | 2021-09-30 | 0.56 | 0.66 | 0.1 | 17 | ||
2021-08-05 | 2021-06-30 | 0.54 | 0.66 | 0.12 | 22 | ||
2021-05-10 | 2021-03-31 | 0.49 | 0.59 | 0.1 | 20 | ||
2021-02-09 | 2020-12-31 | 0.49 | 0.51 | 0.02 | 4 | ||
2020-11-02 | 2020-09-30 | 0.49 | 0.56 | 0.07 | 14 | ||
2020-08-06 | 2020-06-30 | 0.34 | 0.52 | 0.18 | 52 | ||
2020-05-11 | 2020-03-31 | 0.45 | 0.53 | 0.08 | 17 | ||
2020-02-06 | 2019-12-31 | 0.56 | 0.57 | 0.01 | 1 | ||
2019-11-07 | 2019-09-30 | 0.52 | 0.56 | 0.04 | 7 | ||
2019-08-07 | 2019-06-30 | 0.46 | 0.49 | 0.03 | 6 | ||
2019-05-02 | 2019-03-31 | 0.4 | 0.43 | 0.03 | 7 | ||
2019-02-07 | 2018-12-31 | 0.48 | 0.52 | 0.04 | 8 | ||
2018-11-06 | 2018-09-30 | 0.45 | 0.48 | 0.03 | 6 | ||
2018-08-07 | 2018-06-30 | 0.4 | 0.41 | 0.01 | 2 | ||
2018-05-03 | 2018-03-31 | 0.37 | 0.39 | 0.02 | 5 | ||
2018-02-12 | 2017-12-31 | 0.41 | 0.43 | 0.02 | 4 | ||
2017-11-07 | 2017-09-30 | 0.39 | 0.46 | 0.07 | 17 | ||
2017-08-02 | 2017-06-30 | 0.35 | 0.43 | 0.08 | 22 | ||
2017-05-04 | 2017-03-31 | 0.32 | 0.31 | -0.01 | 3 | ||
2017-02-10 | 2016-12-31 | 0.39 | 0.43 | 0.04 | 10 | ||
2016-11-02 | 2016-09-30 | 0.36 | 0.37 | 0.01 | 2 | ||
2016-08-03 | 2016-06-30 | 0.33 | 0.36 | 0.03 | 9 | ||
2016-05-05 | 2016-03-31 | 0.29 | 0.31 | 0.02 | 6 | ||
2016-02-04 | 2015-12-31 | 0.31 | 0.34 | 0.03 | 9 | ||
2015-11-04 | 2015-09-30 | 0.31 | 0.35 | 0.04 | 12 | ||
2015-08-04 | 2015-06-30 | 0.28 | 0.32 | 0.04 | 14 | ||
2015-04-30 | 2015-03-31 | 0.25 | 0.24 | -0.01 | 4 | ||
2015-02-04 | 2014-12-31 | 0.24 | 0.26 | 0.02 | 8 | ||
2014-11-05 | 2014-09-30 | 0.26 | 0.26 | 0.0 | 0 | ||
2014-07-31 | 2014-06-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2014-05-05 | 2014-03-31 | 0.23 | 0.24 | 0.01 | 4 | ||
2014-02-06 | 2013-12-31 | 0.25 | 0.25 | 0.0 | 0 | ||
2013-11-06 | 2013-09-30 | 0.26 | 0.33 | 0.07 | 26 | ||
2013-08-06 | 2013-06-30 | 0.25 | 0.32 | 0.07 | 28 | ||
2013-05-01 | 2013-03-31 | 0.23 | 0.23 | 0.0 | 0 | ||
2013-02-07 | 2012-12-31 | 0.24 | 0.25 | 0.01 | 4 | ||
2012-10-31 | 2012-09-30 | 0.24 | 0.18 | -0.06 | 25 | ||
2012-08-01 | 2012-06-30 | 0.23 | 0.32 | 0.09 | 39 | ||
2012-05-01 | 2012-03-31 | 0.2 | 0.21 | 0.01 | 5 | ||
2012-02-06 | 2011-12-31 | 0.24 | 0.32 | 0.08 | 33 | ||
2011-11-03 | 2011-09-30 | 0.23 | 0.26 | 0.03 | 13 | ||
2011-08-02 | 2011-06-30 | 0.19 | 0.22 | 0.03 | 15 | ||
2011-05-04 | 2011-03-31 | 0.17 | 0.18 | 0.01 | 5 | ||
2011-02-07 | 2010-12-31 | 0.22 | 0.23 | 0.01 | 4 | ||
2010-10-27 | 2010-09-30 | 0.21 | 0.2 | -0.01 | 4 | ||
2010-07-28 | 2010-06-30 | 0.18 | 0.15 | -0.03 | 16 | ||
2010-04-28 | 2010-03-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2010-02-04 | 2009-12-31 | 0.16 | 0.16 | 0.0 | 0 | ||
2009-11-04 | 2009-09-30 | 0.15 | 0.15 | 0.0 | 0 | ||
2009-08-04 | 2009-06-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2009-05-05 | 2009-03-31 | 0.1 | 0.14 | 0.04 | 40 | ||
2009-02-18 | 2008-12-31 | 0.17 | 0.22 | 0.05 | 29 | ||
2008-11-06 | 2008-09-30 | 0.14 | 0.15 | 0.01 | 7 | ||
2008-08-05 | 2008-06-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2008-05-01 | 2008-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2008-03-19 | 2007-12-31 | 0.04 | 0.14 | 0.1 | 250 | ||
2007-11-13 | 2007-09-30 | 0.08 | 0.08 | 0.0 | 0 |
Genpact Corporate Directors
| Carol Lindstrom | Independent Director | Profile | |
| Brian Stevens | Independent Director | Profile | |
| Laura Conigliaro | Independent Director | Profile | |
| Tamara Franklin | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.50) | Dividend Share 0.61 | Earnings Share 2.85 | Revenue Per Share | Quarterly Revenue Growth 0.089 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.